Literature DB >> 9548250

Meningitis bacterium is viable without endotoxin.

L Steeghs, R den Hartog, A den Boer, B Zomer, P Roholl, P van der Ley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548250     DOI: 10.1038/33046

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  108 in total

1.  Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.

Authors:  L Steeghs; H de Cock; E Evers; B Zomer; J Tommassen; P van der Ley
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

Review 2.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

Review 3.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

Review 4.  The role of ATP-binding cassette transporters in bacterial pathogenicity.

Authors:  Victoria G Lewis; Miranda P Ween; Christopher A McDevitt
Journal:  Protoplasma       Date:  2012-01-13       Impact factor: 3.356

5.  Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.

Authors:  N Bhasin; Y Ho; L M Wetzler
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis.

Authors:  Martine P Bos; Jan Tommassen
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  Yersinia pestis is viable with endotoxin composed of only lipid A.

Authors:  Li Tan; Creg Darby
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

8.  Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant.

Authors:  Jeannette N Williams; Paul J Skipp; Holly E Humphries; Myron Christodoulides; C David O'Connor; John E Heckels
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

9.  Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.

Authors:  Susu M Zughaier; Yih-Ling Tzeng; Shanta M Zimmer; Anup Datta; Russell W Carlson; David S Stephens
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37.

Authors:  Jennifer H Moffatt; Marina Harper; Ashley Mansell; Bethany Crane; Timothy C Fitzsimons; Roger L Nation; Jian Li; Ben Adler; John D Boyce
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.